We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canada Looks to Boost Rare Disease Research Via Orphan Drug Pathway
Canada Looks to Boost Rare Disease Research Via Orphan Drug Pathway
November 9, 2012
Health Canada is developing a new approval pathway for orphan drugs as part of an effort to spur development of drugs for conditions that affect less than five in 10,000 patients.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor